Les maladies inflammatoires chronique de l'intestin - Crohn - Recto-colite-ulcéro-hémorragique - Docteur Synapse

Références :
1. Van Assche G., dignass A., Panes J. et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohn’s and colitis, 2010 ; 4 : 7-27.

2. Stange E.F., Travis S.P.L., Vermeire S. et al. The second European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnostis. J Crohn’s and colitis, 2008 ; 2 : 1-23.

3. Abraham C., Cho J.D. Inflammatory bowel disease. N Eng J Med, 2009 ; 361 : 2066-78.

4. Loftus E.V. Clinical Epidemiology of inflammatory bowel disease : incidence, prévalence and environmental influences. Gastroenterology, 2004 ; 126 : 1504-17.

5. Arora G., Singh G., Vadhavkar S. et al. Incidence and Risk of Intestinal and Extra-intestinal complications in Medicaid Patients with Inflammatory. Bowel Disease: A 5-Year Population-Based Study. Dig Dis Sci, 2010 ; 55 : 1689-95.

6. Van Assche G., Dignass A., Reinisch W. et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohn’s Colitis, 2010 ; 4 : 63-101.

7. Van Assche, Dignass A., Bokemeyer B. et al. Second europeen evidence-based consensus on the diagnosis and management of Crohn's disease. J Crohn’s Colitis, 2013 ; 7(1) : 1-33.

8. Fumery M. et al. Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: A metaanalysis of observational studies, J Crohns Colitis, 2013 article in press.

9. Papay P., Tiehsler W., Tilg H. et al. Clinical presentation of venous thromboembolism in inflammatory bowel disease. J Crohn’s Colitis, 2013 ; 7 : 723-9.

10. Grainge M.J. et al. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study Lancet, 2010 ; 375 : 657-63.

11. Rahier J.F., Ben-Horin S., Chowers Y. et al. European evidence-based consensus on the prevention, diagnostic and management of opportunistic infections in inflammatory bowel disease. J Crohn’s Colitis, 2009 ; 3 : 47-91.

12. Navaneethan U., Mukewar S., Venkatesh P., Lopez R., Shen B. J Crohn’s Colitis, 2012 ; 6 : 330-6.

13. Nguyen G.C., Kaplan G.G., Harris M.L. et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol, 2008 ; 103 : 1443-50.

14. Issa M., Vijayapal A., Graham M.B. et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol, 2007 ; 5 : 345-51.

15. Rodemann J.F., Dubberke E.R., Reske K.A., Seo da H., Stone C.D. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol, 2007 ; 5 : 339-44.

16. Kariv R., Navaneethan U., Venkatesh P.G., Lopez R., Shen B. Impact of Clostridium difficile infection in patients with ulcerative colitis. J Crohns Colitis, 2011 ; 5(1) : 34-40.

17. Domenech E., Vega R., Objanguren I. et al. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis, 2008 ; 14 : 1373-9.

18. Kim J., Simpson N., Klipfel N. et al. Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci, 2010 ; 55 : 1059-65.

19. Treton X., Laharie D. Prise en charge d’une colite aiguë grave. Gastro-entérologie Clinique et Biologique, volume 32, Issue 12, décembre 2008, pages 1030-7.

20. Pola S., Patel D., Ramamoorthy S. et al. Strategies for the care of adults hospitalized for active ulcerative colitis. Clin Gastroenterol Hepatol, 2012 ; 10 : 1315-25.

21. Lichtiger S., Present D.H., Kornbluth A. et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med, 1994 ; 330 : 1841-5.

22. Dignass A., Lindsay J., Sturm A. et al. second European evidence-based consensus on the diagnosis and management of ulcerative colitis: current management. J Crohn’s Colitis, 2012 ; 6 : 991-1030.

23. Dignass A., Van Assche G., Lindsay L.O. et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: Current management. J Crohn’s Colitis, 2012 ; 4 : 28-62.

24. Mendoza J.L., Abreu M.T. Biological markers in inflammatory bowel disease: paractical considerations for clinicians. Gastro-entérologie Clinique et biologique, 2009 ; 33 suppl (3) : S158-S173.

25. Lewis J. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology, 2011 ; 140 : 1817-26.

26. Panes J., Bouhnik Y., Reinisch W. Imaging techniques for assessment of inflammatory bowel disease : joint ECCO and ESGAR evidence-based consensus guidelines. J Crohn’s and colitis, 2013 ; 7 : 556-85.

27. https://radiopaedia.org/